Sommaire

• • ·TOC

    Page :A2

    
• • ·Editorial Board

    Page :A8

    
• • ·Information for Authors

    Page :A10

    
• • ·Information for Readers

    Page :A12

    
• • ·Unexpected BNP levels in patients with advanced heart failure: A tale of caution and promise

    Page :187-189

    Mark H. Drazner, James A. de Lemos

    Plan Plan
• • ·Revascularization of coronary atherosclerosis in patients with diabetes mellitus—There is more to it than meets the image intensifier

    Page :190-193

    John L. Petersen, Robert A. Harrington

    
• • ·Invasive versus noninvasive management of ST-elevation acute myocardial infarction: A review of clinical trials and observational studies

    Page :194-199

    Christine A. Beck, Mark J. Eisenberg, Louise Pilote

    Résumé Résumé Plan Plan
• • ·Magnetic resonance imaging of coronary arteries, the ischemic cascade, and myocardial infarction

    Page :200-208

    Theodorus A.M. Kaandorp, Hildo J. Lamb, Jeroen J. Bax, Ernst E. van der Wall, Albert de Roos

    Plan Plan  
• • ·Index

    Page :208

     
• • ·Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)

    Page :209-216

    Kirkwood F. Adams, Gregg C. Fonarow, Charles L. Emerman, Thierry H. LeJemtel, Maria Rosa Costanzo, William T. Abraham, Robert L. Berkowitz, Marie Galvao, Darlene P. Horton, for the ADHERE Scientific Advisory Committee and Investigators 1

    Résumé Résumé Plan Plan  
• • ·Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction : Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25)

    Page :217-226

    Elliott M. Antman, David A. Morrow, Carolyn H. McCabe, Frank Jiang, Harvey D. White, Keith A.A. Fox, Divakar Sharma, Paul Chew, Eugene Braunwald, for the ExTRACT-TIMI 25 Investigators

    Plan Plan  
• • ·Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy–Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial

    Page :227-233

    Marc S. Sabatine, Carolyn H. McCabe, C. Michael Gibson, Christopher P. Cannon

    Résumé Résumé Plan Plan  
• • ·Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia : Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial

    Page :234-239

    John J.P. Kastelein, Philip T. Sager, Eric de Groot, Enrico Veltri

    Résumé Résumé Plan Plan  
• • ·Change of address box

    Page :239

    
• • ·Highlights from the American Heart Association Annual Scientific Sessions 2004: November 7-10, 2004

    Page :240-253

    Svati Shah, Manesh Patel, Abhinav Goyal, Ankie Amos, Ricardo Baeza, Abdul Halabi, Gregory Lam, Robert G. Mitchell, Gustavo Oliveira, Anne Marie Valente

    Plan Plan
• • ·Examining the coverage of influenza vaccination among people with cardiovascular disease in the United States

    Page :254-259

    Umed A. Ajani, Earl S. Ford, Ali H. Mokdad

    Résumé Résumé Plan Plan
• • ·Erythrocyte adhesiveness/aggregation: A novel biomarker for the detection of low-grade internal inflammation in individuals with atherothrombotic risk factors and proven vascular disease

    Page :260-267

    Shlomo Berliner, Ori Rogowski, Stanislav Aharonov, Tamar Mardi, Tatiana Tolshinsky, Meirav Rozenblat, Dan Justo, Varda Deutsch, Jack Serov, Itzhak Shapira, David Zeltzer

    Résumé Résumé Plan Plan  
• • ·Correction

    Page :267

    Antonio Cittadini

    
• • ·Multimarker risk strategy for predicting 1-month and 1-year major events in non–ST-elevation acute coronary syndromes

    Page :268-274

    Vicent Bodí, Juan Sanchis, Àngel Llàcer, Lorenzo Fácila, Julio Núñez, Mauricio Pellicer, Vicente Bertomeu, Vicente Ruiz, Francisco J. Chorro

    Résumé Résumé Plan Plan  
• • ·Early cardiac catheterization is associated with lower mortality only among high-risk patients with ST- and non–ST-elevation acute coronary syndromes: Observations from the OPUS-TIMI 16 trial

    Page :275-283

    Warren J. Cantor, Shaun G. Goodman, Christopher P. Cannon, Sabina A. Murphy, Andrew Charlesworth, Eugene Braunwauld, Anatoly Langer

    Résumé Résumé Plan Plan  
• • ·Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: An open-label randomized pilot study

    Page :e1

    Ezio Faglia, Mantero Manuela, Quarantiello Antonella, Gino Michela, Curci Vincenzo, Caminiti Maurizio, Mattioli Roberto, Morabito Alberto

    Résumé Résumé Plan Plan  
• • ·Plaque erosion in the culprit lesion is prone to develop a smaller myocardial infarction size compared with plaque rupture

    Page :284-290

    Takahiro Hayashi, Takashi Kiyoshima, Masayoshi Matsuura, Masafumi Ueno, Naoya Kobayashi, Hiroshi Yabushita, Atsuhiro Kurooka, Mitsugu Taniguchi, Masaru Miyataka, Akio Kimura, Kinji Ishikawa

    Résumé Résumé Plan Plan  
• • ·Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris

    Page :e1

    Stephen P. Glasser, Theophilus J. Gana, Luz G. Pascual, Kenneth S. Albert

    Résumé Résumé Plan Plan  
• • ·Exercise as an alternative to oral estrogen for amelioration of endothelial dysfunction in postmenopausal women

    Page :291-297

    Paula J. Harvey, Peter E. Picton, Winnie S. Su, Beverley L. Morris, Catherine F. Notarius, John S. Floras

    Résumé Résumé Plan Plan  
• • ·Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathy

    Page :298-303

    Peter Aspelin, Pierre Aubry, Sven-Göran Fransson, Ruth Strasser, Roland Willenbrock, Jonas Lundkvist

    Résumé Résumé Plan Plan  
• • ·Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study

    Page :304-308

    Anne B. Curtis, A. Allen Seals, Robert E. Safford, William Slater, Nicholas G. Tullo, Humberto Vidaillet, David J. Wilber, April Slee, the AFFIRM Investigators 1

    Résumé Résumé Plan Plan  
• • ·Impact of cardioversion strategy on functional capacity in patients with atrial fibrillation: The Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) Study

    Page :309-315

    Susan E. Jasper, Elizabeth A. Lieber, R. Daniel Murray, Carolyn Apperson-Hansen, Ian W. Black, Richard A. Grimm, Linda A. Pape, Allan L. Klein, for the ACUTE Investigators 1

    Résumé Résumé Plan Plan  
• • ·Comparative efficacy of monophasic and biphasic waveforms for transthoracic cardioversion of atrial fibrillation and atrial flutter

    Page :316-321

    Osnat T. Gurevitz, Naser M. Ammash, Joseph F. Malouf, Krishnaswamy Chandrasekaran, Ana Gabriela Rosales, Karla V. Ballman, Stephen C. Hammill, Roger D. White, Bernard J. Gersh, Paul A. Friedman

    Résumé Résumé Plan Plan  
• • ·Detailed bacteriologic tests to identify the origin of transvenous pacing system infections indicate a high prevalence of multiple organisms

    Page :322-328

    Didier Klug, Frédéric Wallet, Salem Kacet, René J. Courcol

    Résumé Résumé Plan Plan  
• • ·Fluvastatin reduces the impact of diabetes on long-term outcome after coronary intervention—A Lescol Intervention Prevention Study (LIPS) substudy

    Page :329-335

    Chourmouzios A. Arampatzis, Dick Goedhart, Patrick W. Serruys, Francesco Saia, Pedro A. Lemos, Pim de Feyter, on behalf of the LIPS Investigators

    Résumé Résumé Plan Plan  
• • ·Repeat stenting for the prevention of the early lumen loss phenomenon in patients with in-stent restenosis : Angiographic and intravascular ultrasound findings of a randomized study

    Page :e1

    Fernando Alfonso, Pablo García, Hector Fleites, Gela Pimentel, Manel Sabaté, Rosana Hernández, Javier Escaned, Camino Bañuelos, Maria J. Pérez-Vizcayno, Raúl Moreno, Carlos Macaya

    Résumé Résumé Plan Plan  
• • ·Randomized comparison of carbon ion–implanted stent versus bare metal stent in coronary artery disease: The Asian Pacific Multicenter Arthos Stent Study (PASS) trial

    Page :336-341

    Young-Hak Kim, Cheol Whan Lee, Myeong-Ki Hong, Seong-Wook Park, Seung-Jea Tahk, Joo-Young Yang, Shigeru Saito, Teguh Santoso, Lizhan Quan, Junbo Ge, Neil J. Weissman, Alexandra J. Lansky, Gary S. Mintz, Seung-Jung Park

    Résumé Résumé Plan Plan  
• • ·A polymorphism of the endothelial nitric oxide synthase promoter is associated with an increase in autonomic imbalance in patients with congestive heart failure

    Page :342-348

    Philip F. Binkley, Enrico Nunziatta, Yiwen Liu-Stratton, Glen Cooke

    Résumé Résumé Plan Plan  
• • ·Screening for heart disease in diabetic subjects

    Page :349-354

    Zhi You Fang, Rebecca Schull-Meade, Rodel Leano, Philip M. Mottram, Johannes B. Prins, Thomas H. Marwick

    Résumé Résumé Plan Plan  
• • ·Myocardial contrast echocardiography accurately reflects transmurality of myocardial necrosis and predicts contractile reserve after acute myocardial infarction

    Page :355-362

    Rajesh Janardhanan, James C.C. Moon, Dudley J. Pennell, Roxy Senior

    Résumé Résumé Plan Plan  
• • ·B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure

    Page :363-369

    J.O. O'Neill, C.E. Bott-Silverman, A.T. McRae, R.W. Troughton, K. Ng, R.C. Starling, J.B. Young

    Résumé Résumé Plan Plan  
• • ·Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMET

    Page :370-376

    Christian Torp-Pedersen, Philip A. Poole-Wilson, Karl Swedberg, John G.F. Cleland, Andrea Di Lenarda, Peter Hanrath, Michel Komajda, Beatrix Lutiger, Marco Metra, Willem J. Remme, Armin Scherhag, Allan Skene, for the COMET Investigators 1

    Résumé Résumé Plan Plan  
• • ·Regarding antithrombotic treatment after coronary stenting in patients on chronic oral anticoagulation

    Page :E1

    Andrea Rubboli, Mauro Colletta, Giuseppe Di Pasquale

    
• • ·Regarding the mechanism of statin-induced myopathy

    Page :E3

    Bernard Noël

    
• • ·Aortic stenosis and angiotensin-converting enzyme inhibitors—Rupture of an ancient paradigm?

    Page :E5

    Carlos F. Barrera-Ramírez, Luis R. Pineda-Pompa, Hermes Ilarraza

    
• • ·Reply

    Page :E7

    Anand Chockalingam

    
• • ·Letter by Spodick

    Page :E9

    David H. Spodick

    
• • ·Reply

    Page :E11

    Apoor S. Gami, Thomas A. Holly, James E. Rosenthal

    
• • ·Cardiovascular disease in Latin America

    Page :E13

    Josefina Medina-Lezama, Julio Chirinos-Pacheco, Julio Alonso Chirinos

    
• • ·Transseptal left heart catheterization as an alternative to retrograde left ventricular catheterization for patients with aortic stenosis

    Page :E15

    Tsung O. Cheng